Literature DB >> 8506910

Drainage of subretinal fluid with the argon laser.

E P Fitzpatrick1, D Abbott.   

Abstract

We performed 115 scleral-buckling procedures for primary rhegmatogenous retinal detachments in which the argon endolaser drained subretinal fluid. The laser was set at 0.80 to 1.25 W and 0.5 second; the endolaser probe was held adjacent to, but not touching, the choroid. The procedure was successful in 112 of 115 (97.0%) patients. When inadequate drainage occurred, the use of the penetrating diathermy tip was successful. The only major complications were subretinal hemorrhages that had migrated posterior to the buckle in two patients (1.70%), retinal perforation in one patient (0.87%), and retinal incarceration in one patient (0.87%). Laser drainage caused a slow, controlled drainage of subretinal fluid.

Entities:  

Mesh:

Year:  1993        PMID: 8506910     DOI: 10.1016/s0002-9394(14)73643-8

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  4 in total

1.  Transscleral drainage of subretinal fluid revisited.

Authors:  D McLeod
Journal:  Br J Ophthalmol       Date:  1995-08       Impact factor: 4.638

2.  Prospective, randomised, controlled trial comparing suture needle drainage and argon laser drainage of subretinal fluid.

Authors:  G W Aylward; G Orr; S D Schwartz; P K Leaver
Journal:  Br J Ophthalmol       Date:  1995-08       Impact factor: 4.638

3.  Does cryotherapy before drainage increase the risk of intraocular haemorrhage and affect outcome? A prospective, randomised, controlled study using a needle drainage technique and sustained ocular compression.

Authors:  I A Pearce; D Wong; J McGalliard; C Groenewald
Journal:  Br J Ophthalmol       Date:  1997-07       Impact factor: 4.638

Review 4.  Iatrogenic retinal traumas in ophthalmic surgery.

Authors:  Daniele Tognetto; Maria Teresa di Lauro; Daniela Fanni; Adelia Zagidullina; Luca Michelone; Giuseppe Ravalico
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-07-05       Impact factor: 3.117

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.